Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för bedaquiline. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

38 träffar

Bibliografisk träff 2012-01-18

Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.

Wallis RS, Jakubiec W, Mitton-Fry M, Ladutko L, Campbell S, Paige D, Silvia A, Miller PF.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0030479

Bibliografisk träff 2011-12-12

Pharmacokinetics and pharmacodynamics of TMC207 and its N-desmethyl metabolite in a murine model of tuberculosis.

Rouan MC, Lounis N, Gevers T, Dillen L, Gilissen R, Raoof A, Andries K.

Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.00720-11

Bibliografisk träff 2011-08-30

Speciation analysis of bromine-containing drug metabolites in feces samples from a human in vivo study by means of HPLC/ICP-MS combined with on-line isotope dilution.

Meermann B, Bockx M, Laenen A, Van Looveren C, Cuyckens F, Vanhaecke F.

Anal Bioanal Chem · clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1007/s00216-011-5339-y

Bibliografisk träff 2011-08-17

Probing the interaction of the diarylquinoline TMC207 with its target mycobacterial ATP synthase.

Haagsma AC, Podasca I, Koul A, Andries K, Guillemont J, Lill H, Bald D.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0023575

Bibliografisk träff 2011-06-09

Short-course chemotherapy with TMC207 and rifapentine in a murine model of latent tuberculosis infection.

Zhang T, Li SY, Williams KN, Andries K, Nuermberger EL.

Am J Respir Crit Care Med · research-article; journal article; research support, n.i.h., extramural · DOI 10.1164/rccm.201103-0397oc

Bibliografisk träff 2009-12-28

Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor.

Huitric E, Verhasselt P, Koul A, Andries K, Hoffner S, Andersson DI.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.01611-09

Bibliografisk träff 2009-12-01

[R207910 (TMC207): a new antibiotic for the treatment of tuberculosis].

Lounis N, Guillemont J, Veziris N, Koul A, Jarlier V, Andries K.

Med Mal Infect · review; journal article · DOI 10.1016/j.medmal.2009.09.007

Bibliografisk träff 2008-10-23

A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosis.

Veziris N, Ibrahim M, Lounis N, Chauffour A, Truffot-Pernot C, Andries K, Jarlier V.

Am J Respir Crit Care Med · research support, non-u.s. gov't; journal article · DOI 10.1164/rccm.200711-1736oc